Critical Analytics for Manufacturing of Personalised Medicine Interdisciplinary Research Group, Singapore-MIT Alliance in Research and Technology, 1 Create Way, #04-13/14, Singapore, 138602, Singapore.
Critical Analytics for Manufacturing of Personalised Medicine Interdisciplinary Research Group, Singapore-MIT Alliance in Research and Technology, 1 Create Way, #04-13/14, Singapore, 138602, Singapore; NUS Tissue Engineering Program, Life Sciences Institute, National University of Singapore 27 Medical Drive1, DSO (Kent Bridge) Building, Level 4, Singapore, 11751, Singapore; Department of Orthopaedic Surgery, National University of Singapore, 1E Kent Ridge Road, NUHS Tower block 11, Singapore, 119288, Singapore.
Biomaterials. 2020 May;240:119881. doi: 10.1016/j.biomaterials.2020.119881. Epub 2020 Feb 18.
Mesenchymal stem cells (MSCs) have the capability to differentiate into multiple cell lineages, and produce trophic factors to facilitate tissue repair and regeneration, and disease regression. However, the heterogeneity of MSCs, whether inherent or developed during culture expansion, has a significant impact on their therapeutic efficacy. Therefore, the ability to identify and select an efficacious subpopulation of MSCs targeting specific tissue damage or disease holds great clinical significance. In this study, we separated three subpopulations from culture expanded human bone marrow derived MSCs according to cell size, using a high-throughput label-free microfluidic cell sorting technology. The size-sorted MSC subpopulations varied in tri-lineage differentiation potencies. The large MSCs showed the strongest osteogenesis, medium-size MSCs were advantageous in chondrogenesis and adipogenesis, and the small MSCs showed the weakest tri-lineage differentiation. The size-sorted MSC subpopulations also exhibited different secretome profiles. The large MSC secretome possessed highest levels of osteogenic promotor proteins and senescence-associated factors, but lower levels of osteogenic inhibitor proteins compared to the medium-size MSC secretome. The medium-size MSC secretome had high levels of chondrogenic promotor proteins, and contained lower levels of chondrogenic inhibitor proteins compared to the large MSC secretome. The secretome of size-sorted MSC subpopulations showed differences in paracrine effects. We found that the secretome of large MSCs enhanced osteogenic and adipogenic potencies during MSC culture expansion, but also induced cell senescence; and the secretome of medium-size MSCs promoted chondrogenesis. This study demonstrates size-dependent differentiation potency and secretome profile of MSC subpopulations, and provides an effective and practical technology to isolate the respective subpopulations, which may be used for more targeted tissue repair and regeneration.
间充质干细胞(MSCs)具有向多个细胞谱系分化的能力,并产生营养因子以促进组织修复和再生以及疾病消退。然而,MSCs 的异质性,无论是固有还是在培养扩增过程中发展的,对其治疗效果有重大影响。因此,能够识别和选择针对特定组织损伤或疾病的有效 MSC 亚群具有重要的临床意义。在这项研究中,我们根据细胞大小,使用高通量无标记微流控细胞分选技术,从培养扩增的人骨髓来源的 MSC 中分离出三个亚群。大小分选的 MSC 亚群在三系分化潜能上有所不同。大 MSC 表现出最强的成骨能力,中等大小 MSC 有利于软骨生成和脂肪生成,而小 MSC 表现出最弱的三系分化。大小分选的 MSC 亚群也表现出不同的分泌组谱。大 MSC 分泌组具有最高水平的成骨促进蛋白和衰老相关因子,但与中等大小 MSC 分泌组相比,成骨抑制剂蛋白水平较低。中等大小 MSC 分泌组具有高水平的软骨形成促进蛋白,并且与大 MSC 分泌组相比,软骨形成抑制剂蛋白水平较低。大小分选的 MSC 亚群的旁分泌作用存在差异。我们发现大 MSC 的分泌组在 MSC 培养扩增过程中增强了成骨和脂肪生成能力,但也诱导了细胞衰老;而中等大小 MSC 的分泌组促进了软骨生成。这项研究证明了 MSC 亚群的大小依赖性分化能力和分泌组谱,并提供了一种有效实用的技术来分离各自的亚群,这可能用于更有针对性的组织修复和再生。